Novartis | Kapitalizacja Rynkowa



Market Capitalization Zmiana Data
AbbVie USD 347.08B 19.2B 2025-08
Alcon AG CHF 41.59B 3.16B 2025-03
Almirall EUR 2.29B 195.31M 2025-06
Amgen USD 154.93B 4.8B 2025-08
AstraZeneca GBP 169.84B 45.67B 2025-08
Autolus Therapeutics Ltd 412.5M 0 2025-08
Bayer EUR 25.19B 108.07M 2025-08
Biogen USD 19.23B 818M 2025-08
Bristol-Myers Squibb USD 90.13B 4.07B 2025-08
Eli Lilly USD 615.07B 123.72B 2025-08
Fresenius EUR 24.68B 636.46M 2025-08
Fresenius Medical Care EUR 12.17B 2.1B 2025-08
Galapagos EUR 1.86B 291.92M 2025-08
Genmab DKK 87.78B 6.9B 2025-08
Gilead Sciences USD 147.49B 9.58B 2025-08
GlaxoSmithKline GBP 57.33B 1.09B 2025-08
GRIFOLS EUR 5.4B 928.14M 2025-08
Hikma Pharmaceutical GBP 4.42B 226.35M 2024-12
J&J USD 366.71B 32.94B 2025-06
Merck EUR 46.98B 847.82M 2025-08
Merck USD 201.3B 2.52B 2025-08
Novartis CHF 189.79B 66.39B 2025-08
Novartis USD 240.64B 6.39B 2025-08
Novo Nordisk A/S 1.59T 370.19B 2025-08
Orion EUR 7B 1.99B 2025-08
Pfizer USD 139.98B 2.45B 2025-08
Philips EUR 20.65B 999.2M 2025-08
Recordati EUR 10.37B 608.61M 2025-08
Regeneron Pharmaceuticals USD 62.39B 6.52B 2025-08
Sanofi EUR 101.06B 998.99M 2025-08
UCB EUR 37.38B 10.41B 2024-12


Novartis Kapitalizacja Rynkowa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.